Find your path to Mike
72 people in our graph share verified history with Mike — schools, employers, funds. One of them is your warm intro.
About
Mike Khan is Chief Executive Officer of Argonaute RNA Limited, where he leads the company's scientific work, and previously served as Chief Medical Officer of Silence Therapeutics plc. He has over 25 years of experience in preclinical, translational and clinical R&D, including advancing siRNA drugs from IND through Phase 2, and formerly held roles as Clinical Lecturer in Medicine at UCLH and Head of Molecular Medicine and Associate Professor of Medicine at the University of Warwick. He works as a clinician at the University Hospitals of Coventry and Warwickshire NHS Trust and serves as an expert advisor to NICE and the European Commission.
CEO at Argonaute
Intro paths
In turn, Mike can intro founders to Argonaute's investors below.
Argonaute's investors · 1
Co-founders at Argonaute
Experience
- ARGONAUTE RNA LIMITEDChief Executive Officercurrent2021 — presentUnited Kingdom
- NICEExpert advisorcurrent2016 — present
- University of WarwickAssociate Professor of Medicine1998 — 2020University of Warwick and University Hospitals of Coventry and Warwickshire NHS
- University of WarwickHead of Molecular Medicine2002 — 2007Biomedical Research Institute
- Lambeth and Southwark Clinical Commissioning GroupsSecondary Care Doctor to the Governing Body2016 — 2020London Area, United Kingdom
- Silence Therapeutics plcHead of Translational Medicine and Executive Director2013 — 2016London Area, United Kingdom
- Silence Therapeutics plcChief Medical Officer and Executive Director2013 — 2015London Area, United Kingdom
- Silence Therapeutics plcNon-executive director2012 — 2013
- National Institute for Health and Care Excellence (NICE)Advisor to the Clinical Guidelines Development Group2012 — 2014
- University College London Hospitals NHS Foundation TrustSenior registrar1994 — 1998
- University College LondonMRC Training Fellow1988 — 1992Department of Zoology
Skills & more
+8 more
Cardiovascular DiseaseBiotechnologyLife SciencesMolecular BiologyClinical ResearchOncologyScienceMedical ResearchLanguages French · German · Spanish
- Accredited in General Internal Medicine, Diabetes, Endocrinology and Metabolic medicine — General Medical Council UK
From Mike's professional profile.
Frequently asked questions
- Who is Mike Khan?
- Mike Khan is Chief Executive Officer of Argonaute RNA Limited, where he leads the company's scientific work, and previously served as Chief Medical Officer of Silence Therapeutics plc. He has over 25 years of experience in preclinical, translational and clinical R&D, including advancing siRNA drugs from IND through Phase 2, and formerly held roles as Clinical Lecturer in Medicine at UCLH and Head of Molecular Medicine and Associate Professor of Medicine at the University of Warwick. He works as a clinician at the University Hospitals of Coventry and Warwickshire NHS Trust and serves as an expert advisor to NICE and the European Commission.
- Where does Mike Khan work?
- Mike Khan is CEO at Argonaute.
- Where did Mike Khan go to school?
- Mike Khan studied at Guy's Hospital Medical School (Bachelor of Medicine, Bachelor of Surgery (MBBS)); King's College London (Bachelor of Medicine, Bachelor of Surgery (MBBS)); UCL (Doctor of Philosophy (PhD), Developmental Neurobiology).
Same school
Also attended King's College London375
+ 369 more
Shared employers
Also worked at ARGONAUTE RNA LIMITED1
Also worked at University of Warwick18
+ 12 more
